BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3929404)

  • 1. Cost-yield of routine Papanicolaou smear screening in a clinic for sexually transmitted diseases.
    Tavelli BG; Judson FN; Hetrick AE; Root CJ
    Sex Transm Dis; 1985; 12(3):110-3. PubMed ID: 3929404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
    Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
    Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Papanicolaou smear return in a hospital-based adolescent and young adult clinic.
    Kahn JA; Goodman E; Huang B; Slap GB; Emans SJ
    Obstet Gynecol; 2003 Mar; 101(3):490-9. PubMed ID: 12636952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intention to return for papanicolaou smears in adolescent girls and young women.
    Kahn JA; Goodman E; Slap GB; Huang B; Emans SJ
    Pediatrics; 2001 Aug; 108(2):333-41. PubMed ID: 11483797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of low-grade squamous intraepithelial lesions during pregnancy.
    Jain AG; Higgins RV; Boyle MJ
    Am J Obstet Gynecol; 1997 Aug; 177(2):298-302. PubMed ID: 9290443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of speculoscopy in the evaluation of women with atypical Papanicolaou smears. Improved cost effectiveness by selective colposcopy.
    Massad LS; Lonky NM; Mutch DG; Mann WJ; Blanco JS; Vasilev SA; Finan MA; Scotti RJ
    J Reprod Med; 1993 Mar; 38(3):163-9. PubMed ID: 8387595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of cervical cytology screening in a sexually transmitted diseases clinic.
    Lyttle H; Platts WM; MacLean AB
    Genitourin Med; 1985 Oct; 61(5):330-4. PubMed ID: 2995239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
    Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
    Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies.
    Marcus AC; Crane LA; Kaplan CP; Reading AE; Savage E; Gunning J; Bernstein G; Berek JS
    Med Care; 1992 Mar; 30(3):216-30. PubMed ID: 1538610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the Papanicolaou smear and the cervigram: sensitivity, specificity, and cost analysis.
    Tawa K; Forsythe A; Cove JK; Saltz A; Peters HW; Watring WG
    Obstet Gynecol; 1988 Feb; 71(2):229-35. PubMed ID: 3336558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beliefs about Papanicolaou smears and compliance with Papanicolaou smear follow-up in adolescents.
    Kahn JA; Chiou V; Allen JD; Goodman E; Perlman SE; Emans SJ
    Arch Pediatr Adolesc Med; 1999 Oct; 153(10):1046-54. PubMed ID: 10520612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Papanicolaou smear and the obstetric patient: a simple test with great benefits.
    Michael CW
    Diagn Cytopathol; 1999 Jul; 21(1):1-3. PubMed ID: 10405797
    [No Abstract]   [Full Text] [Related]  

  • 13. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
    Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
    Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening in an urban emergency department.
    Hogness CG; Engelstad LP; Linck LM; Schorr KA
    Ann Emerg Med; 1992 Aug; 21(8):933-9. PubMed ID: 1497160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Koilocytotic atypia and underlying dysplasia.
    Shepherd J; Lynch W
    J Fam Pract; 1991 Aug; 33(2):168-71. PubMed ID: 1890397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild cervical dysplasia. Experience in a family planning clinic.
    Sondheimer SJ; Casey MV; Rubin M; Mangan C; Atkinson B; Huggins GR
    J Reprod Med; 1983 Jul; 28(7):489-95. PubMed ID: 6887154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preparation of additional smears from a cervical scrape: impact on the rate of detection of cervical neoplasia.
    Al-Awadhi R; Byrne M; Coleman DV
    Cytopathology; 2001 Jun; 12(3):151-6. PubMed ID: 11380556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family planning provider referral, facilitation behavior, and patient follow-up for abnormal Pap smears.
    Felix HC; Bronstein J; Bursac Z; Stewart MK; Foushee HR; Klapow J
    Public Health Rep; 2009; 124(5):733-44. PubMed ID: 19753952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of abnormal Papanicolaou smears among women of different races.
    Carey P; Gjerdingen DK
    J Fam Pract; 1993 Dec; 37(6):583-7. PubMed ID: 8245810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of abnormal Papanicolaou smears in pregnancy.
    Lurain JR; Gallup DG
    Obstet Gynecol; 1979 Apr; 53(4):484-8. PubMed ID: 440652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.